1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Cuba Pharmaceuticals and Healthcare Report Q3 2016

Cuba Pharmaceuticals and Healthcare Report Q3 2016

  • May 2016
  • -
  • Business Monitor International
  • -
  • 66 pages

Includes 3 FREE quarterly updates

BMI View: Pharmaceutical investment and commercial opportunities in Cuba will increase at a slow paceover the forecast period. Cuba's biotechnology industry is set to benefit from the lifting of the US tradeembargo, while the world-class Cuban medical research and manufacturing capacity will be furtherdeveloped as the country's global reach and integration strengthens. Meanwhile, we highlight an expectedrapid growth in the healthcare tourism industry in Cuba in the next years. However, we expect progress tobe slow in terms of removing hindrances to foreign investment in Cuba, while the domestic pharmaceuticalmarket, albeit forecast to grow over the forecast period, will remain relatively small in value terms.

Headline Expenditure Projections

- Pharmaceuticals: CUP1.51bn (USD1.51bn) in 2015 to CUP1.61bn (USD1.61bn) in 2016; +6.3% inlocal currency terms and US dollar terms. Forecast in line with last quarter.

- Healthcare: CUP11.18bn (USD11.18bn) in 2015 to CUP13.21bn (USD13.21bn) in 2016; +18.1% inlocal currency terms and US dollar terms. Forecast revised upwards from last quarter.

Table Of Contents

Cuba Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Cuba 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Cuba 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Cuba 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Cuba 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Cuba 2012-2020) 17
Pharmaceutical Trade Forecast 18
Table: Pharmaceutical Trade Data And Forecasts (Cuba 2014-2020) 21
Industry Risk/Reward Index 22
Americas Risk/Reward Index 22
Cuba Risk/Reward Index 27
Rewards 27
Risk 27
Regulatory Review 29
Intellectual Property Issues 31
Pricing Regime 32
Reimbursement Regime 32
Market Overview 34
Healthcare Sector 35
Table: Healthcare Resources (Cuba 2010-2015) 36
Table: Healthcare Personnel (Cuba 2010-2015) 37
Table: Healthcare Activity (Cuba 2010-2015) 37
Research and Development 37
Clinical Trials 39
Epidemiology 40
Competitive Landscape 43
Research-Based Industry 43
Table: Biotechnology, Pharmaceutical and Healthcare's Members of CAMARACUBA, 2010 44
Table: Licensed Local Pharmaceutical Producers, April 2011 46
Table: Foreign Producers with GMP Certificates, April 2011 51
Generic Drugmakers 53
Pharmaceutical Distribution 54
Pharmaceutical Retail Sector 54
Demographic Forecast 55
Table: Population Headline Indicators (Cuba 1990-2025) 56
Table: Key Population Ratios (Cuba 1990-2025) 56
Table: Urban/Rural Population and Life Expectancy (Cuba 1990-2025) 57
Table: Population By Age Group (Cuba 1990-2025) 57
Table: Population By Age Group % (Cuba 1990-2025) 58
Glossary 60
Methodology 62
Pharmaceutical Expenditure Forecast Model 62
Healthcare Expenditure Forecast Model 62
Notes On Methodology 63
Risk/Reward Index Methodology 64
Index Overview 65
Table: Pharmaceutical Risk/Reward Index Indicators 65
Indicator Weightings 66

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in New Zealand - Forecast

  • December 2016
    71 pages
  • Therapy  

  • New Zealand  

View report >

Therapy Market in the UK

  • December 2016
    194 pages
  • Therapy  

    Infectious Dise...  

    Eye Disease  

  • United Kingdom  

View report >

Opioid and Anesthetics Market in Australia

  • December 2016
    5 pages
  • Opioid  

    Anesthetics  

    Analgesic  

  • Australia  

View report >

Related Market Segments :

Pharmaceutical
Healthcare

Country Reports

Cuba

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.